ICD10 code of Progressive Osseous Heteroplasia and ICD9 code

Progressive Osseous Heteroplasia (POH) does not have a unique, dedicated ICD-10 or ICD-9 code; instead, it is typically classified under broader categories for bone disorders or heterotopic ossification. Specifically, clinicians often use ICD-10 code M61.0 (Myositis ossificans traumatica) or M61.9 (Calcification and ossification of muscle, unspecified) for billing and documentation, though these codes do not fully capture the genetic nature of Progressive Osseous Heteroplasia.

What is the clinical nature of Progressive Osseous Heteroplasia?

Progressive Osseous Heteroplasia is an ultra-rare genetic condition characterized by the formation of bone in soft tissues, such as skin, muscle, and subcutaneous fat (heterotopic ossification). Unlike other conditions that cause soft tissue calcification, Progressive Osseous Heteroplasia is caused by inactivating mutations in the GNAS gene. Because the condition is so rare, it is often misdiagnosed, making accurate coding and clinical documentation vital for patients navigating the healthcare system.

How is Progressive Osseous Heteroplasia diagnosed?

Diagnosis of Progressive Osseous Heteroplasia is primarily clinical, based on the presence of dermal ossification during infancy or early childhood, followed by progressive deep connective tissue ossification. Genetic testing for GNAS mutations is the gold standard for confirmation. When seeking care, patients should be aware of the following diagnostic steps:

• Physical examination to identify cutaneous ossification (small, hard nodules in the skin).


• Imaging studies such as X-rays or CT scans to assess the extent of heterotopic ossification.


• Genetic counseling and molecular testing to identify the specific GNAS mutation.


• Clinical evaluation by an endocrinologist or geneticist familiar with GNAS-related disorders.

Is Progressive Osseous Heteroplasia hereditary?

Progressive Osseous Heteroplasia is typically caused by a sporadic, *de novo* mutation, meaning it is not usually inherited from parents. However, because it involves the GNAS gene, it is part of a spectrum of related disorders. Understanding the inheritance pattern of Progressive Osseous Heteroplasia is essential for family planning and long-term medical management.

Next steps

• Consult with a medical geneticist to confirm a diagnosis of Progressive Osseous Heteroplasia through molecular testing.


• Connect with the DiseaseMaps.org community to share experiences with others navigating this rare condition.


• Maintain a detailed medical record, as the lack of a specific ICD code for Progressive Osseous Heteroplasia can make insurance authorization for specialized care challenging.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult a qualified healthcare professional regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Progressive Osseous Heteroplasia.


• Orphanet: Rare disease database entry for Progressive Osseous Heteroplasia (ORPHA:2807).


• OMIM (Online Mendelian Inheritance in Man): Entry #166350 regarding GNAS-related disorders.


• IFOPA (International FOP Association): Resources regarding heterotopic ossification and related conditions.